FDA Press Statement || The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion for Booster Injection (IM) for 12 years of age and older.

Share this Post!

The FDA Approves the Certificate of Product Registration (CPR) for COVID-19 Vaccine Tozinameran + Famtozinameran (15 mcg/15 mcg)/0.3 mL Dispersion for Booster Injection (IM) for 12 years of age and older.

#FDA #Educate #Regulate #Monitor

See more:-> https://bit.ly/3OMVFji